Endothelial dysfunction in preeclampsia

Seminars in Reproductive Endocrinology

Volumn 16, Issue 1, 1998, Pages 5-15

  Roberts, James M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Atherosclerosis; Cytokine; Endothelium; Oxidative stress; Prreclampsia

Indexed keywords

CYTOKINE;

ECLAMPSIA; ENDOTHELIUM INJURY; HUMAN; MOTHER FETUS RELATIONSHIP; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW;

EID: 0031783198     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016248     Document Type: Review

References (102)

1. Chesley LC. Hypertensive disorders of pregnancy. New York: Appleton-Century-Crofts, 1978
2. ACOG Committee on Technical Bulletins. Hypertension in pregnancy. ACOG Technical Bulletin 1996;219:1-8
3. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol 1991;18:661-682
4. Roberts JM. Pregnancy related hypertension. In: Creasy RK, Resnik R, eds. Maternal fetal medicine: Principles and practice. Philadelphia: W.B. Saunders, 1994
5. Roberts JM, Redman CWG. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993;341:1447-1451
6. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93: 1049-1059
7. Brosens IA, Rebertson WB, Dixon HG. The role of the spiral artheries in the pathogenesis of preeclampsia. In: Wynn R (ed). Obstet Gynecol Ann 1979;177-191
8. Pijneneborg R, Robertson WB, Brosens I, Dixon G. Reveiw article: Trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta 1981;2:71-92
9. Assali PM, Assali NS. Vascular changes in the decidua associated with eclamptogenic toxemia. Am J Clin Pathol 1950;20:1099
10. Malee MP, Malee KM, Azuma SD, Taylor RN, Roberts JM. Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia. J Clin Endocrinol Metab 1992;74:1095-1100
11. deJong CLD, Dekker GA, Sibai BM. The renin-angiotensin-aldosterone system in preeclampsia. Clin Perinatol 1991;18:683-710
12. Talledo OE. Renin-angiotensin system in normal and toxemic pregnancies. I. Angiotensin infusion test. Am J Obstet Gynecol 1966;96:141-143
13. Talledo OE, Chesley LC, Zuspan FP. Renin-angiotensin system in normal and toxemic pregnancies III. Differential sensitivity to angiotension II and norepinephrine in toxemia of pregnancy. Am J Obstet Gynecol 1968;100:218-221
14. Roberts JM, May WJ. Consumptive coagulopathy in severe preeclampsia. Obstet Gynecol 1976;48:163-166
15. Hutt R, Ogunniyi SO, Sullivan HF, Elder MG. Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol 1994:146-149
16. Leiberman JR, Hagay ZJ, Mazor M, et al. Plasma antithrombin III levels in preeclampsia and chronic hypertension. Int J Gynecol Obstet 1988;27:21-24
17. Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation. Gynecol Obstet Invest 1987;24:170-178
18. Weiner CP. Preeclampsia-eclampsia syndrome and coagulation. Clin Perinatol 1991;18:713-716
19. Campbell DM, Campbell AJ. Evans blue disappearance rate in normal and preeclamptic pregnancy. Part B, hypertension in pregnancy. Clin Exp Hypertens 1983;2:163-169
20. Gant M, Daley G, Chand S, Whalley P, Macdonald P. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-2689
21. Gallery EDM, Saunders DM, Boyce ES, Györy AZ. Relation between plasma volume and uric acid in the development of hypertension in pregnancy. In: Bonnar MA, MacGillivray I, Symonds MS (eds). Pregnancy Hypertension. Baltimore: University Park Press, 1980
22. Shembrey MA, Noble AD. An instructive case of abdominal pregnancy. Aust NZ J Obstet Gynaecol 1995;35:220-221
23. Page EW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 1939;37:291-293
24. Taddei S, Salvetti A. Pathogenetic factors in hypertension endothelial factors. Clin Exp Hypertens 1996;18:323-335
25. Baylis C, Suto T, Conrad K. Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: Studies in the rat and implications for preeclampsia. Hypertens Pregnancy 1996;15:147-169
26. Weiner CP. Thrombotic microangiopathy in pregnancy and the postpartum peroid. Sem Hematol 1987;24:119-129
27. United States and Canadian Academy of Pathology I. Cardiovascular pathology: Clinicopathologic correlations and pathogenetic mechanisms. In: Vogel FS (ed). Monographs in Pathology. Baltimore: Williams and Wilkins, 1995
28. Vanhoutte PM, Scott-Burden T. The endothelium in health and disease [Review]. Texas Heart Inst J 1994;21:62-67
29. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-1204
30. McCartney CP, Spargo BH, Larincz AB, Lefebure Y, Newton RE. Renal structure and function in pregnant patients with acute hypertension. Am J Obstet Gynecol 1964;90: 579-590
31. Remuzzi G, Marchesi D, Zoja C, et al. Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 1980;20:105-110
32. Redman CWG, Denson KWE, Beilin LJ, et al. Factor-VIII consumption in preeclampsia. Lancet 1977;2:1249
33. Walsh SW. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985;152:335-340
34. Zwaginga JJ, Sixma JJ, de Groot PG. Activiation of endothelial cells induces platelet thrombus formation on their matrix. Arteriosclerosis Thrombosis 1990:49-61
35. Fitzgerald DJ, Entman SS, Mulloy K, Fitzgerald GA. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987;75:956-963
36. Hsu C-D, Iriye B, Johnson TRB, Witter FR, Hong S-F, Chan DW. Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol 1993;169:148-149
37. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 1991;165:724-727
38. Clark BA, Halvorson L, Sachs B, Epstein FH. Plasma endothelin levels in preeclampsia: Elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 1992:962-968
39. Greer IA, Leask R, Hodson BA, Dawes J, Kilpatrick DC, Liston WA. Endothelin elastase, and endothelial dysfunction in pre-eclampsia. Lancet 1991;337:558-558
40. Kraayenbrink AA, Dekker GA, Van Kamp GJ, Van G. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 1993;169:160-165
41. Sudo N, Kamoi K, Ishibashi M, Yamaji T. Plasma endothelin-1 and big endothelin-1 levels in women with preeclampsia. Acta Endocrinologica 1993;129:114-120
42. Taylor RN, Varma M, Teng NNH, Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990;71:1675-1677
43. Florijn KW, Derkx FH, Visser W, et al. Plasma immunoreactive endothelin-1 in pregnant women with and without pre-eclampsia. J Cardiovasc Pharmacol 1991;17:S446-S448
44. Kraayenbrink AA, Dekker GA, Vankamp GJ, Vangeijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 1993;169:160-165
45. Wolff K, Nisell H, Carlstrom K, et al. Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. Regul Pept 1996;67:211-216
46. Rust OA, Bofill JA, Zappe DH, Hall JE, Burnett JC, Martin JN. The origin of endothelin-1 in patients with severe preeclampsia. Obstet Gynecol 1997;89:754-757
47. Djurovic S, Schjetlein R, Wisloff F, Haugen G, Berg K. Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia. Br J Obstet Gynaecol 1997;104:466-470
48. Lyall F, Greer IA, Macara LM, Walker JJ, Kingdom JCP. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation? Br J Obstet Gynaecol 1994;101:485-487
49. Fckling SA, Whitley GS, Nussey SS. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation? [letter; comment]. Br J Obstet Gynaecol 1995;102:173-174
50. Murphy-Ullrich JE, Mosher DF. Fibronectin and disease processes. Connective Tissue Disease: Molecular Pathology of the Extracellular Matrix. In: Uitto, J, Perejda, AJ (eds). Connective Tissue Disease: Molecular Pathology of the Extracellular Matrix, New York: Marcel Dekker, 1986:455-473
51. Frolich EP. Elevated fibronectin levels and preeclampsia. Am J Obstet Gynecol 1989;160:1022-1023
52. Peters JH, Sporn LA, Ginsberg MH, Wagner DD. Human endothelial cells synthesize, process, and secrete fibronictin molecules bearing an alternatively spliced type III homology (EDI). Blood 1990,75:1801-1808
53. Hsu CD, Iriye B, Johnson TRB, Witter FR, Hong SF, Chan DW. Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol 1992;169:148-149
54. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990;76:2024-2029
55. Friedman SA, deGroot CJM, Taylor RN, Heilbron DC, Roberts JM. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 1994;170:838-841
56. Hsu CD, Copel JA, Hong S-F, Chan DW. Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension. Obstet Gynecol 1995;86:897-899
57. Chen CK, Lee CN, Shyu MK, et al. Fibronectin levels in normal pregnancy and preeclampsia. J Formosan Med Assoc 1994;93:921-924
58. Deng L, Bremme K, Hansson LO, Blomback M. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994;84:941-945
59. Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 1993;169:160-165
60. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC, Roberts JM. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 1991;165:895-901
61. Akgul C, Salmayenli N, Ibrahimoglu L. Plasma fibronectin levels and pre-eclampsia. Int J Gynaecol Obstet 1994; 44:280-281
62. Taylor RN, Crombleholme WR, Friedman SA, Jones LA, Casal DC, Roberts JM. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 1991;165:895-901
63. Lockwood C, Peters J. Increased plasma levels of ED1+ celllular fibronectin preced the clinical signs of preeclampsia. Am J Obstet Gynecol 1990;162:358-362
64. Musci TJ, Roberts JM, Rodgers GM, Taylor RN. Mitogenic activity is increased in the sera of preeclamptic women before delivery. Am J Obstet Gynecol 1988;159:1446-1451
65. Rodgers GM, Taylor RN, Roberts JM. Preeclampsia is assciated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988;159:908-914
66. Roberts JM, Edep ME, Goldfien A, Taylor RN. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: Morphological and biochemical evidence. Am J Reproduct Immunol 1992;27: 101-108
67. Roberts JM, Hubel CA, Taylor RN. Endothelial dysfunction yes, cytotoxicity no! (Letter) Am J Obstet Gynecol 1995;173:978-979
68. McCartney CP, Spargo BH, Larincz AB, Lefebure Y, Newton RE. Renal structure and function in pregnant patients with acute hypertension. Am J Obstet Gynecol 1964;90:579-590
69. Dadak C, Ulrich W, SInzinger H. Morphological changes in the umbilical arteries of babies born to pre-eclamptic mothers: an ultrastructural study. Placenta 1984;5:419-126
70. Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia. Am J Obstet Gynecol 1990;163:943-953
71. Taylor RN, Musci TJ, Kuhn RW, Roberts JM. Partial characterization of a novel growth factor from the blood of women with preeclampsia. J Clin Endocrinol Metab 1990;70:1285-1291
72. Kupfermine MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994;170:1752-1759
73. Opsjon SL, Novick D, Wathen NC, Cope AP, Wallach D, Aderka D. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. J Reprod Immunol 1995;29:119-134
74. Nakashima A, Kobayashi T, Terao T. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors. Gynecol Obstet Invest 1996;42:95-101
75. Walsh SC. Lipid peroxidation in pregnancy. Hypertension Pregnancy 1994;13:1-25
76. Hubel CA, Griggs KC, McLaughlin MK. Lipid peroxdiation and altered vascular function in vitamin E-deficient rats. Heart Circul Physiol 1989;161:H1539-H1545
77. Janes SL, Kyle PM, Redman C, Goodall AH. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb Haemostas 1995;74:1059-1063
78. Greer IA, Dawes J, Johnston TA, Calder AA. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol 1991;78:28-32
79. Smarason AK, Sargent IL, Redman CWG. Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia. Am J Obstet Gynecol 1996; 174:787-793
80. Smarason AK, Sargent IL, Starkey PM, Redman CWG. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 1993;100:943-949
81. Cockell AP, Learmont JG, Smarason AK, Redman CWG, Sargent IL, Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 1997;104:235-240
82. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991;98:973-979
83. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 1993;169:1112-1118
84. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-241
85. Stone J, Lockwood C, Berkowitz G, Alvarez M, Lapinski R, Berkowitz R. Risk factors for severe preeclampsia. Obstet Gynecol 1994;83:357-361
86. Sermer M, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes - The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995;173:146-156
87. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications [Review] [51 refs]. Am J Obstet Gynecol 1996;175:1365-1370
88. Fisher KA, Luger A, Spargo BH, Lindheimer MD. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis. Medicine 1981;60:267-276
89. Rosing U, Samsioe G, Olund A, Johansson B, Kallner A. Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia. Hormone Metabol Res 1989;21:376-382
90. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996;174:975-982
91. Vangaal LF, Zhang AG, Steijaert MM, Deleeuw IH. Human obesity: From lipid abnormalities to lipid oxidation. Int J Obesity 1995;19:S21-S26
92. LaRosa JC. Women, lipoproteins, and cardiovascular disease risk [Review]. Int Fertil 1992;2:63-71
93. Parthasarathy S, Rankin SM. Role of oxidized low density lipoprotein in atherogenesis. Prog Lipid Res 1992;31:127-143
94. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rodgers GM, McLaughlin MK. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 1989; 161:1025-1034
95. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis. Obstet Gynecol 1997;89:403-408
96. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol 1993;68:495-519
97. Walsh SW. Prostaglandins in pregnancy. Reproduct Endocrinol Infertil Genet 1989;5:1-21
98. Davidge S, Stranko C, Roberts J. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996;174:1008-1013
99. Fitzgerald DJ, Entmann SS, Mulloy K, Fitzgerald GA. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987,75:956-963
100. Taylor RN, Heilbron DC, Roberts JM. Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am J Obstet Gynecol 1991;163:1839-1844
101. McCartney CP. Pathological anatomy of acute hypertension of pregnancy. Circulation 1964;30(Suppl II)1:37-42
102. Sheppard BL, Bonnar J. Uteroplacental arteries and hypertensive pregnancy. In: Bonnar JMI, Symonds G, (eds). Pregnancy hypertension. Baltimore: University Park, 1980.